30.88
Schlusskurs vom Vortag:
$31.86
Offen:
$31.59
24-Stunden-Volumen:
612.86K
Relative Volume:
0.43
Marktkapitalisierung:
$2.43B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-41.17
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
-4.78%
1M Leistung:
+7.33%
6M Leistung:
-0.26%
1J Leistung:
+1.51%
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie VCYT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
VCYT
Veracyte Inc
|
30.88 | 2.42B | 399.58M | -54.04M | 40.13M | -0.75 |
![]()
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
![]()
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-20 | Eingeleitet | Craig Hallum | Buy |
2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
2024-10-16 | Eingeleitet | UBS | Buy |
2024-10-10 | Eingeleitet | Guggenheim | Buy |
2024-02-23 | Bestätigt | Needham | Buy |
2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
2022-01-07 | Eingeleitet | Stephens | Overweight |
2021-11-18 | Fortgesetzt | Goldman | Buy |
2021-06-15 | Eingeleitet | Raymond James | Outperform |
2021-02-18 | Fortgesetzt | Needham | Buy |
2021-01-28 | Eingeleitet | Truist | Buy |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
2019-07-31 | Eingeleitet | Lake Street | Buy |
2019-07-02 | Eingeleitet | Needham | Buy |
2018-11-29 | Herabstufung | Janney | Buy → Neutral |
2018-10-31 | Hochstufung | Janney | Neutral → Buy |
2017-11-07 | Herabstufung | Janney | Buy → Neutral |
2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
2017-08-31 | Fortgesetzt | BTIG Research | Buy |
2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
2015-06-11 | Bestätigt | Leerink Partners | Outperform |
2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Veracyte, Inc. $VCYT Stake Trimmed by Great Lakes Advisors LLC - MarketBeat
AQR Capital Management LLC Lowers Stock Position in Veracyte, Inc. $VCYT - Defense World
Veracyte (NASDAQ:VCYT) CEO Sells $233,153.47 in Stock - MarketBeat
Is Veracyte Inc. still worth holding after the dip2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Can trapped investors hope for a rebound in Veracyte Inc.Trade Entry Summary & Low Risk Entry Point Tips - Newser
Will Veracyte Inc. stock go up soonQuarterly Trade Summary & High Yield Stock Recommendations - Newser
Real time scanner hits for Veracyte Inc. explainedEntry Point & Low Risk Entry Point Tips - Newser
Tools to monitor Veracyte Inc. recovery probabilityJuly 2025 Trends & Risk Managed Investment Signals - Newser
Price momentum metrics for Veracyte Inc. explainedQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Will earnings trigger a reversal in Veracyte Inc.July 2025 WrapUp & Free Daily Entry Point Trade Alerts - Newser
Bridgeway Capital Management LLC Sells 41,300 Shares of Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Veracyte, Inc. $VCYT Shares Purchased by Parkman Healthcare Partners LLC - MarketBeat
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
Transcript : Veracyte, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 04 - MarketScreener
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation - Investing.com
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting - Business Wire
Raymond James Financial Inc. Raises Stake in Veracyte, Inc. $VCYT - MarketBeat
Veracyte CEO Stapley sells $233k in shares By Investing.com - Investing.com South Africa
Veracyte CEO Stapley sells $233k in shares - Investing.com India
Can Veracyte Inc. expand into new marketsWeekly Stock Report & Low Drawdown Momentum Trade Ideas - beatles.ru
Is Veracyte Inc. stock forming a triangle patternPortfolio Value Summary & Fast Gain Stock Trading Tips - beatles.ru
PDT Partners LLC Trims Stock Position in Veracyte, Inc. $VCYT - MarketBeat
What are the future prospects of Veracyte Inc.July 2025 Retail & Weekly Top Gainers Alerts - 뉴스영
Trexquant Investment LP Has $5.59 Million Stake in Veracyte, Inc. $VCYT - MarketBeat
Is Veracyte Inc. stock ready for a breakout2025 Performance Recap & AI Driven Stock Reports - Newser
Can Veracyte Inc. continue delivering strong returnsWeekly Stock Summary & Free Growth Oriented Trading Recommendations - خودرو بانک
Magnetar Financial LLC Makes New Investment in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Volatility clustering patterns for Veracyte Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - Newser
Can Veracyte Inc. hit a new high this monthQuarterly Trade Report & Daily Market Momentum Tracking - Newser
Using Ichimoku Cloud for Veracyte Inc. technicalsCPI Data & Proven Capital Preservation Methods - Newser
Can Veracyte Inc. rally from current levelsPortfolio Value Report & Long-Term Investment Growth Plans - Newser
Does Veracyte Inc. have strong fundamentalsMarket Risk Report & Community Verified Trade Alerts - خودرو بانک
How to use Fibonacci retracement on Veracyte Inc.Weekly Trade Report & Low Risk Investment Opportunities - Newser
Will Veracyte Inc. price bounce be sustainableWeekly Loss Report & Free Long-Term Investment Growth Plans - Newser
Hsbc Holdings PLC Boosts Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Full technical analysis of Veracyte Inc. stockBreakout Watch & Real-Time Buy Signal Alerts - Newser
Is Veracyte Inc. forming a double bottomJuly 2025 Weekly Recap & Daily Entry Point Trade Alerts - خودرو بانک
How to recover losses in Veracyte Inc. stockRecession Risk & Long-Term Safe Investment Plans - Newser
What is the long term forecast for Veracyte Inc. stockPortfolio Gains Report & Fast Momentum Entry Tips - خودرو بانک
Can Veracyte Inc. recover in the next quarter2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
Using data filters to optimize entry into Veracyte Inc.July 2025 PreEarnings & Risk Controlled Daily Plans - Newser
Veracyte, Inc. $VCYT Shares Bought by Rafferty Asset Management LLC - MarketBeat
Driehaus Capital Management LLC Grows Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
What hedge funds are buying Veracyte Inc.Market Risk Summary & Real-Time Volume Surge Alerts - خودرو بانک
Russell Investments Group Ltd. Lowers Holdings in Veracyte, Inc. $VCYT - MarketBeat
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):